$BMY News

Bristol Myers Squibb Gets FDA Nod For Novel Multiple Myeloma Treatment

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Appeals court revives $6.7B lawsuit against Bristol Myers Squibb

Bristol-Myers Squibb Receives FDA Approval For ZENBEXUS In Combination With Daratumumab And Hyaluronidase-fihj and Dexamethasone For Patients with Multiple Myeloma

Is Bristol Myers’ US$2.3 Billion Houston Manufacturing Campus Altering The Investment Case For BMY?

AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk

BMS Plans $2.3B Houston Manufacturing Campus

BMS banks on Texas for $2.3bn multi-modal manufacturing facility

Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas

Bristol Myers Squibb to build $2.3B advanced manufacturing plant in Houston, creating 500 jobs

Bristol Myers Squibb to build $2.3 billion Houston campus

Major pharmaceutical company plans $2.3B Houston manufacturing campus, 500 jobs

Houston wins $2.3B manufacturing campus from pharma giant

Bristol Myers Squibb opening pharmaceutical manufacturing campus near Houston

Bristol Myers Squibb plans $2.3 billion Houston manufacturing campus

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers Squibb To Invest $2.3B In Houston Manufacturing Campus, Creating Nearly 500 Jobs

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Argus Research Upgrades Bristol-Myers Squibb (BMY)

Schrödinger and BMS expand partnership to deploy AI for drug discovery